dsm-firmenich secures 3-FL HMO market access in Europe : vimarsana.com

dsm-firmenich has secured European market access for its 3-fucosyllactose (3-FL) ingredient, one of the most abundant human milk oligosaccharides (HMO) in human milk.

Related Keywords

Marta Miks , Panel On Nutrition , Regulatory Affairs , European Food Safety Authority , European Commission , Senior Regulatory Scientific Affairs , Novel Food , Scientific Opinion , Novel Foods , Food Allergens , Senior Regulatory , Scientific Affairs Manager , Suppliers , Upplements , Infant Amp Maternal , Airy Based Ingredients , Robiotics , Rebiotics Amp Postbiotics , Ut Digestive Health , Mmune Support , Aternal Amp Infant Health , Mo , Egulation ,